XML 71 R46.htm IDEA: XBRL DOCUMENT v3.23.1
STOCKHOLDERS’ EQUITY (DEFICIT) (Details Narrative) - USD ($)
 12 Months Ended
Oct. 25, 2022
Sep. 15, 2022
Mar. 18, 2022
Nov. 04, 2021
Oct. 21, 2021
Mar. 18, 2021
Dec. 31, 2022
Dec. 31, 2021
Sep. 08, 2022
Dec. 10, 2021
Dec. 09, 2021
Nov. 08, 2021
Dec. 31, 2020
Class of Stock [Line Items]                          
Preferred stock, par value             $ 0.01 $ 0.01          
Number of shares of common stock authorized             12,612,862 23,108,955          
Common stock, shares authorized             75,000,000 75,000,000   2,500,000 1,175,000    
Aggregate purchase of common stock, shares   838,549                      
Description of stock options held by officer and director   (i) Lance Alstodt, the Company’s President, Chief Executive Officer and Chairman of the Board: 335,538 shares, (ii) Francisco Silva, the Company’s Vice President of Research and Development and a director: 335,538 shares; (iii) Robert Kristal, the Company’s Chief Financial Officer: 10,490 shares; (iv) Robert Paccasassi, the Company’s Vice President of Quality Assurance and Regulatory Compliance: 8,277 shares; (v) Nickolay Kukekov, one of the Company’s directors: 25,236 shares; (vi) Patrick F. Williams, one of the Company’s directors: 10,490 shares; and (vii) David Rosa, one of the Company’s directors: 10,490 shares.                      
Vested common stock, shares             15,898 5,000          
Aggregate common stock services rendered             $ 135,888 $ 25,476          
Warrants issued             4,791,082            
Number of option issued to purchase shares of common stock       140,824                  
Number of Options Granted             25,000 838,550          
Share-based compensation arrangement by share-based payment award, description       Such options are exercisable to the extent of 50% on the date of grant and 50% quarterly over a period of two years commencing one year from the date of grant.                  
Exercise price             $ 5.08 $ 5.08   $ 5.08 $ 13.50   $ 5.08
Weighted average grant date fair value of stock options granted             $ 4.88 $ 5.05          
Restricted Stock Units (RSUs) [Member]                          
Class of Stock [Line Items]                          
Number of shares of common stock authorized             4,735,108 3,671,503          
Chief Executive Officer and Chairman of the Board and its Vice President [Member] | Restricted Stock Units (RSUs) [Member]                          
Class of Stock [Line Items]                          
Number of option issued to purchase shares of common stock     24,876                    
Exercise price     $ 4.21                    
Patrick F Williams [Member]                          
Class of Stock [Line Items]                          
Number of Options Granted       10,490                  
Mr. Alstodt [Member]                          
Class of Stock [Line Items]                          
Number of option issued to purchase shares of common stock       140,824                  
Mr. Silva [Member]                          
Class of Stock [Line Items]                          
Number of option issued to purchase shares of common stock       42,059                  
Dr Nickolay Kukekov [Member]                          
Class of Stock [Line Items]                          
Number of option issued to purchase shares of common stock       25,236                  
Scientific Advisory Board [Member]                          
Class of Stock [Line Items]                          
Number of Options Granted       110,767                  
Two Employment Agreements [Member] | Chief Executive Officer and Chairman of the Board and its Vice President [Member]                          
Class of Stock [Line Items]                          
Number of option issued to purchase shares of common stock           586,959              
Description of share based payment award vesting rights           vested to the extent of 50% on the date of grant, 25% on the one-year anniversary of the grant date and 25% on the two-year anniversary of the grant date.              
Two Employment Agreements [Member] | Chief Executive Officer and Chairman of the Board and its Vice President [Member] | Restricted Stock Units (RSUs) [Member]                          
Class of Stock [Line Items]                          
Number of option issued to purchase shares of common stock           293,479              
Exercise price           $ 47.60              
Fair value of restricted stock units           $ 13,969,624              
Common Stock [Member]                          
Class of Stock [Line Items]                          
Stock issued new issues               2,300,000          
Common Stock [Member] | Maximum [Member]                          
Class of Stock [Line Items]                          
Share price   $ 13.50                      
Common Stock [Member] | Minimum [Member]                          
Class of Stock [Line Items]                          
Share price   $ 5.08                      
Warrant [Member]                          
Class of Stock [Line Items]                          
Stock issued new issues         22,917   51,370 147,832          
Cashless exercise of warrants         25,000     170,473          
Warrants issued             51,370            
Weighted average estimated fair value of warrants granted             $ 2.28 $ 11.77          
2021 Stock Incentive Plan [Member]                          
Class of Stock [Line Items]                          
Number of shares of common stock authorized           1,175,000              
Series A Preferred Stock [Member]                          
Class of Stock [Line Items]                          
Preferred stock, shares issued                       1,543,158  
Preferred stock, par value                       $ 0.01  
Preferred stock, liquidation preference                       $ 0.001  
Series B Preferred Stock [Member]                          
Class of Stock [Line Items]                          
Preferred stock, shares issued             1,543,158   1,543,158        
Preferred stock voting rights             The terms of the Series B are substantially identical to those of the Series A, except that, among other things, the limitation on beneficial ownership of common stock of the Company upon a conversion of the Series B into Common Stock, and the limitation on the number of votes attributable to the Series B, is 9.99% of the then outstanding Common Stock of the Company instead of 4.99% as provided for the Series A.            
Preferred stock voting percentage             9.99%            
Series B Preferred Stock [Member] | Beneficial Ownership [Member]                          
Class of Stock [Line Items]                          
Preferred stock voting percentage             9.99%            
Ownership percentage             9.50%            
Common Class B [Member]                          
Class of Stock [Line Items]                          
Debt conversion, converted instrument, shares issued 25,000                        
Conversion of stock shares 1,518,158                        
Common Class B [Member] | Auctus Fund LLC [Member]                          
Class of Stock [Line Items]                          
Debt conversion, converted instrument, shares issued 25,000